Literature DB >> 17540954

Variation of the transcription factor 7-like 2 (TCF7L2) gene predicts impaired fasting glucose in healthy young adults: the Cardiovascular Risk in Young Finns Study.

Olli T Raitakari1, Tapani Rönnemaa, Risto Huupponen, Liisa Viikari, Meng Fan, Jukka Marniemi, Nina Hutri-Kähönen, Jorma S A Viikari, Terho Lehtimäki, Terho Lehtimäkimd.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17540954     DOI： 10.2337/dc07-0539

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  11 in total

Review 1.  Determining genetic risk factors for pediatric type 2 diabetes.

Authors:  Angharad R Morgan
Journal:  Curr Diab Rep       Date:  2012-02       Impact factor: 4.810

2.  Transcription factor 7-like 2 (TCF7L2) polymorphism and context-specific risk of impaired fasting glucose in African American and Caucasian adults: the atherosclerosis risk in communities (ARIC) study.

Authors:  Yu Yan; Kari E North; Gerardo Heiss; Ronald Klein; Cynthia J Girman; Ethan M Lange; James S Pankow; Frederick L Brancati; Eric Boerwinkle
Journal:  Diabetes Metab Res Rev       Date:  2010-07       Impact factor: 4.876

3.  Association testing of TCF7L2 polymorphisms with type 2 diabetes in multi-ethnic youth.

Authors:  D Dabelea; L M Dolan; R D'Agostino; A M Hernandez; J B McAteer; R F Hamman; E J Mayer-Davis; S Marcovina; J M Lawrence; C Pihoker; J C Florez
Journal:  Diabetologia       Date:  2010-11-26       Impact factor: 10.122

4.  Single nucleotide transcription factor 7-like 2 (TCF7L2) gene polymorphisms in antiislet autoantibody-negative patients at onset of diabetes.

Authors:  Jeesuk Yu; Andrea K Steck; Sunanda Babu; Liping Yu; Dongmei Miao; Kim McFann; John Hutton; George S Eisenbarth; Georgeanna Klingensmith
Journal:  J Clin Endocrinol Metab       Date:  2008-12-02       Impact factor: 5.958

5.  TCF7L2 variants associate with CKD progression and renal function in population-based cohorts.

Authors:  Anna Köttgen; Shih-Jen Hwang; Evadnie Rampersaud; Josef Coresh; Kari E North; James S Pankow; James B Meigs; Jose C Florez; Afshin Parsa; Daniel Levy; Eric Boerwinkle; Alan R Shuldiner; Caroline S Fox; W H Linda Kao
Journal:  J Am Soc Nephrol       Date:  2008-07-23       Impact factor: 10.121

6.  Genetic predisposition to long-term nondiabetic deteriorations in glucose homeostasis: Ten-year follow-up of the GLACIER study.

Authors:  Frida Renström; Dmitry Shungin; Ingegerd Johansson; Jose C Florez; Göran Hallmans; Frank B Hu; Paul W Franks
Journal:  Diabetes       Date:  2010-09-24       Impact factor: 9.461

7.  The rs7903146 Variant in the TCF7L2 Gene Increases the Risk of Prediabetes/Type 2 Diabetes in Obese Adolescents by Impairing β-Cell Function and Hepatic Insulin Sensitivity.

Authors:  Catrina Cropano; Nicola Santoro; Leif Groop; Chiara Dalla Man; Claudio Cobelli; Alfonso Galderisi; Romy Kursawe; Bridget Pierpont; Martina Goffredo; Sonia Caprio
Journal:  Diabetes Care       Date:  2017-06-13       Impact factor: 19.112

8.  Tissue-specific alternative splicing of TCF7L2.

Authors:  Ludmila Prokunina-Olsson; Cullan Welch; Ola Hansson; Neeta Adhikari; Laura J Scott; Nicolle Usher; Maurine Tong; Andrew Sprau; Amy Swift; Lori L Bonnycastle; Michael R Erdos; Zhi He; Richa Saxena; Brennan Harmon; Olga Kotova; Eric P Hoffman; David Altshuler; Leif Groop; Michael Boehnke; Francis S Collins; Jennifer L Hall
Journal:  Hum Mol Genet       Date:  2009-07-14       Impact factor: 6.150

Review 9.  Animal models of GWAS-identified type 2 diabetes genes.

Authors:  Gabriela da Silva Xavier; Elisa A Bellomo; James A McGinty; Paul M French; Guy A Rutter
Journal:  J Diabetes Res       Date:  2013-04-11       Impact factor: 4.011

10.  Wnt Pathway Gene Expression Is Associated With Arterial Stiffness.

Authors:  Allison L Kuipers; Iva Miljkovic; Emma Barinas-Mitchell; Cara S Nestlerode; Ryan K Cvejkus; Victor W Wheeler; Yingze Zhang; Joseph M Zmuda
Journal:  J Am Heart Assoc       Date:  2020-01-30       Impact factor: 5.501
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.